QR Code

Risk factors and outcome of COVID-19 in patients with hematological malignancies

Abstract Background Prognostic factors of poor outcome in patients with hematological malignancies and COVID-19 are poorly defined. Patients and methods This was a Spanish transplant group and cell therapy (GETH) multicenter retrospective observational study, which included a large cohort of blood c...

Description complète

Enregistré dans:
Auteurs principaux: José Luis Piñana, Rodrigo Martino, Irene García-García, Rocío Parody, María Dolores Morales, Gonzalo Benzo, Irene Gómez-Catalan, Rosa Coll, Ignacio De La Fuente, Alejandro Luna, Beatriz Merchán, Anabelle Chinea, Dunia de Miguel, Ana Serrano, Carmen Pérez, Carola Diaz, José Luis Lopez, Adolfo Jesús Saez, Rebeca Bailen, Teresa Zudaire, Diana Martínez, Manuel Jurado, María Calbacho, Lourdes Vázquez, Irene Garcia-Cadenas, Laura Fox, Ana I. Pimentel, Guiomar Bautista, Agustin Nieto, Pascual Fernandez, Juan Carlos Vallejo, Carlos Solano, Marta Valero, Ildefonso Espigado, Raquel Saldaña, Luisa Sisinni, Josep Maria Ribera, Maria Jose Jimenez, Maria Trabazo, Marta Gonzalez-Vicent, Noemí Fernández, Carme Talarn, Maria Carmen Montoya, Angel Cedillo, Anna Sureda, Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH)
Format: Artigo
Langue:Inglês
Publié: BMC 2020-08-01
Collection:Experimental Hematology & Oncology
Accès en ligne:http://link.springer.com/article/10.1186/s40164-020-00177-z
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires